Skip to main content

Table 1 Baseline characteristics of the participants

From: N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial

 

Placebo (n = 21)

n3 FA (n = 20)

P

Mean ± SD

Mean ± SD

Age (years)

60.91 ± 8.56

60.32 ± 9.53

0.830

BMI (kg/m2)

24.10 ± 2.94

23.50 ± 3.17

0.525

Gender, n (%)

Female

8 (36.4)

8 (36.4)

 

Male

14 (63.6)

14 (63.6)

Patients on OADs (%)

 

12 (57.1)

10 (50.0)

 

Patients on AHDs (%)

 

16 (76.1)

14 (70.0)

 
  1. Definitions – BMI Body mass index, OADs Oral antidiabetic drugs, AHDs Antihypertensive drugs